Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103746633 | 10374663 | 3 | F | 20130506 | 20160824 | 20140811 | 20160906 | EXP | DE-CELGENEUS-062-50794-13061571 | CELGENE | 75.00 | YR | F | Y | 0.00000 | 20160906 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103746633 | 10374663 | 1 | PS | VIDAZA | AZACITIDINE | 1 | Subcutaneous | U | 0 | 150 | MG | INJECTION | |||||||
| 103746633 | 10374663 | 2 | C | MIRTAZAPIN | MIRTAZAPINE | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103746633 | 10374663 | 1 | Refractory anaemia with an excess of blasts |
| 103746633 | 10374663 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103746633 | 10374663 | HO |
| 103746633 | 10374663 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103746633 | 10374663 | Hepatotoxicity | |
| 103746633 | 10374663 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103746633 | 10374663 | 1 | 20130308 | 0 |